Clinical Trial Update: Decitabine With or Without Valproic Acid in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating decitabine with or without valproic acid in relapsed or refractory non-Hodgkin lymphoma, including Burkitt lymphoma, diffuse large B-ce…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burkitt Lymphoma
• Diffuse Large B-cell Lymphoma
• Mantle Cell Lymphoma

Drugs mentioned

• Dacogen (decitabine)
• VALPROIC ACID (Valproic acid)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma | Phase 1 | Status: COMPLETED